Importance Neurological and neuropsychiatric symptoms that persist or develop three
months after the onset of COVID-19 pose a significant threat to the global healthcare system …

Cerebral small vessel disease (CSVD) is the leading cause of vascular cognitive impairment
and is associated with COVID-19. However, contributing factors that often accompany CSVD …

Abstract Objective COVID-19 (SARS-CoV-2) has been associated with neurological
sequelae even in those patients with mild respiratory symptoms. Patients experiencing …

Background There is increasing evidence that SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) not only affects the respiratory tract but also influence the central …

The literature on cases of acute disseminated encephalomyelitis (ADEM) associated with
SARS-CoV-2 infection has been rapidly increasing. However, the specific clinical features of …

Purpose To comprehensively evaluate the incidences of abnormal neuroimaging findings in
patients with COVID-19 via a systematic review and meta-analysis. Method PubMed …

Background: In this study, we aimed to determine the global prevalence, chronological order
of symptom appearance, and mortality rates with regard to hemorrhagic and ischemic stroke …

Post COVID-19 syndrome is determined as signs and symptoms that appear during or after
an infection consistent with SARS-CoV-2 disease, persist for more than 12 weeks and are …

Objective: Magnetic resonance imaging (MRI) of the brain or spine examines the findings as
well as the time interval between the onset of symptoms and other adverse effects in …

Abstract Background Coronavirus disease 2019 (COVID-19) has been associated with
nervous system involvement, with more than one-third of COVID-19 patients experiencing …